This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Thai Bao Dieu Hien: Innovator in Nucleic Acid Nanoparticles
Introduction
Thai Bao Dieu Hien is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on nucleic acid nanoparticles. His research focuses on developing advanced solutions for medical challenges, including acute kidney injury.
Latest Patents
Thai Bao Dieu Hien holds a patent for "Three-dimensional self-assembled nucleic acid nanoparticles and use thereof." This invention relates to a novel drug delivery system that utilizes three-dimensional self-assembled nucleic acid nanoparticles. The tetrahedral structure of these nanoparticles demonstrates excellent renal-targeting ability. This technology can effectively reduce p53 and caspase 3 expression in vitro and in vivo, making it a promising approach for the prevention or treatment of acute kidney injury.
Career Highlights
Thai Bao Dieu Hien is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential impact on medical treatments and drug delivery methodologies. With a focus on innovative solutions, he continues to push the boundaries of scientific research.
Collaborations
His notable coworker in this field is Dae-Ro Ahn, with whom he collaborates on various research projects. Their combined expertise contributes to advancements in the development of effective drug delivery systems.
Conclusion
Thai Bao Dieu Hien's work in the field of nucleic acid nanoparticles represents a significant advancement in medical technology. His innovative approach to drug delivery systems has the potential to improve treatment outcomes for patients suffering from acute kidney injury.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
